Cargando…
Cbl-b silenced human NK cells respond stronger to cytokine stimulation
Autores principales: | Lametschwandtner, Guenther, Sachet, Monika, Haslinger, Isabella, Mühleisen, Hannes, Loibner, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649341/ http://dx.doi.org/10.1186/2051-1426-3-S2-P230 |
Ejemplares similares
-
Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing
por: Sachet, Monika, et al.
Publicado: (2015) -
Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy
por: Lametschwandtner, Guenther, et al.
Publicado: (2014) -
Overcoming immune-cell unresponsiveness in cancer
por: Lametschwandtner, Guenther, et al.
Publicado: (2013) -
Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors
por: Triozzi, Pierre, et al.
Publicado: (2015) -
Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency
por: Huemer, Martina, et al.
Publicado: (2016)